{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:01:10Z","timestamp":1789506070089,"version":"build-2803163510"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/idoj.idoj_284_19","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T04:11:50Z","timestamp":1638763910000},"page":"135","source":"Crossref","is-referenced-by-count":36,"title":["Update on management of morphea (Localized Scleroderma) in children"],"prefix":"10.4103","volume":"11","author":[{"given":"Renu","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TSathish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.280253-1","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","article-title":"Scleroderma in children and adolescents: Localized scleroderma and systemic sclerosis","author":"Li","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"key-10.4103\/2229-5178.280253-4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/pde.13605","article-title":"Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review","author":"Mansour","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/2229-5178.280253-5","first-page":"213","article-title":"Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis","author":"Badea","year":"2009","journal-title":"Rheumatology"},{"key":"key-10.4103\/2229-5178.280253-6","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/2229-5178.280253-7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaad.2010.02.065","article-title":"Clinicohistopathological correlations in juvenile localized scleroderma: Studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes","author":"Sung","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000246685","article-title":"Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea","author":"Kencka","year":"1995","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.280253-9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0190-9622(94)70113-X","article-title":"Bullous morphea: Clinical, pathologic, and immunopathologic evaluation of thirteen cases","author":"Daoud","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1440-1754.2012.02435.x","article-title":"Odontostomatologic involvement in juvenile localised scleroderma of the face","author":"Trainito","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"key-10.4103\/2229-5178.280253-11","first-page":"933","article-title":"Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: Case-based review","author":"Jie","year":"2019","journal-title":"Rheumatol Int"},{"key":"key-10.4103\/2229-5178.280253-12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1534734607308731","article-title":"Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma","author":"Wollina","year":"2007","journal-title":"Int J Low Extrem Wounds"},{"key":"key-10.4103\/2229-5178.280253-13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0019-5154.108079","article-title":"Disabling pansclerotic morphea of childhood with extracutaneous manifestations","author":"Kura","year":"2013","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.280253-14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","article-title":"Pediatric scleroderma: Systemic or localized forms","author":"Torok","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"key-10.4103\/2229-5178.280253-15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jaad.2009.10.017","article-title":"Early localized morphea mimicking an acquired port-wine stain","author":"Nijhawan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-16","doi-asserted-by":"crossref","unstructured":"Kharkar VD, Abak BA, Mahajan SA. Linear atrophoderma of moulin: A rare entity. Indian J Dermatol Venereol Leprol 2018;84:591-4.","DOI":"10.4103\/ijdvl.IJDVL_136_17"},{"key":"key-10.4103\/2229-5178.280253-17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01451298","article-title":"Melorheostosis: Report of a new case with linear scleroderma","author":"Birtane","year":"1998","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-18","first-page":"192","article-title":"Melorheostosis: Two atypical cases","author":"Sureka","year":"2014","journal-title":"Indian J Radiol Imaging","ISSN":"https:\/\/id.crossref.org\/issn\/0971-3026","issn-type":"print"},{"key":"key-10.4103\/2229-5178.280253-19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3899\/jrheum.130029","article-title":"Clinical features of morphea patients with the pansclerotic subtype: A cross-sectional study from the Morphea in Adults and Children (MAC cohort)","author":"Kim","year":"2014","journal-title":"J Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-20","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: A work in progress toward development of localized scleroderma outcome measures","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0929-8266(00)00097-5","article-title":"Skin imaging with high frequency ultrasound - preliminary results","author":"Szyma\u0144ska","year":"2000","journal-title":"Eur J Ultrasound"},{"key":"key-10.4103\/2229-5178.280253-22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaad.2010.08.027","article-title":"Activity assessment in morphea using color Doppler ultrasound","author":"Wortsman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/41.10.1178","article-title":"Juvenile-onset localized scleroderma activity detection by infrared thermography","author":"Martini","year":"2002","journal-title":"Rheumatology"},{"key":"key-10.4103\/2229-5178.280253-24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: Part II.Outcome measures and treatment","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","article-title":"Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review","author":"Martini","year":"2018","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/2229-5178.280253-26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/bjd.17312","article-title":"Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma","author":"Kurzinski","year":"2019","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.280253-27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00431-018-3144-8","article-title":"Development of minimum standards of care for juvenile localized scleroderma","author":"Constantin","year":"2018","journal-title":"Eur J Pediatr"},{"key":"key-10.4103\/2229-5178.280253-28","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/art.38444","article-title":"A28: Description of the juvenile localized scleroderma subgroup of the CARRA registry","author":"Wu","year":"2014","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/2229-5178.280253-29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","article-title":"Consensus-based recommendations for the management of juvenile localised scleroderma","author":"Zulian","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/2229-5178.280253-30","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma.A single-center study","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1600-0560.2009.01201.x","article-title":"Elastic fiber pattern in scleroderma\/morphea","author":"Walters","year":"2009","journal-title":"J Cutan Pathol"},{"key":"key-10.4103\/2229-5178.280253-32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaad.2016.12.020","article-title":"Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort","author":"Walker","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-33","first-page":"719685","article-title":"Neurologic involvement in scleroderma en coup de sabre","author":"Amaral","year":"2012","journal-title":"Autoimmune Dis"},{"key":"key-10.4103\/2229-5178.280253-34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2214\/AJR.07.2163","article-title":"MRI findings in deep and generalized morphea (Localized Scleroderma)","author":"Horger","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"key-10.4103\/2229-5178.280253-35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key-10.4103\/2229-5178.280253-36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0.1% in active plaque morphea","author":"Kroft","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/2229-5178.280253-37","doi-asserted-by":"crossref","unstructured":"Stefanaki C, Stefanaki K, Kontochristopoulos G, Antoniou C, Stratigos A, Nicolaidou E, et al. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study. J Dermatol 2008;35:712-8.","DOI":"10.1111\/j.1346-8138.2008.00552.x"},{"key":"key-10.4103\/2229-5178.280253-38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ddg.12724","article-title":"German guidelines for the diagnosis and therapy of localized scleroderma","author":"Kreuter","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"key-10.4103\/2229-5178.280253-39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5114\/reum.2017.72628","article-title":"Morphea \u2013 Selected local treatment methods and their effectiveness","author":"Narbutt","year":"2017","journal-title":"Reumatologia"},{"key":"key-10.4103\/2229-5178.280253-40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","author":"Cunningham","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","article-title":"First case series on the use of calcipotriol-betamethasone dipropionate for morphoea","author":"Dytoc","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.280253-42","doi-asserted-by":"crossref","first-page":"e1010983","DOI":"10.1080\/19381980.2015.1010983","article-title":"A vitamin D analog inhibits Th2 cytokine- and TGF\u03b2 -induced periostin production in fibroblasts: A potential role for vitamin D in skin sclerosis","author":"Terao","year":"2015","journal-title":"Dermatoendocrinol"},{"key":"key-10.4103\/2229-5178.280253-43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000335560","article-title":"Topical imiquimod 5% cream for pediatric plaque morphea: A prospective, multiple-baseline, open-label pilot study","author":"Pope","year":"2011","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.280253-44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: Follow-up study on 17 patients","author":"Joly","year":"1994","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.280253-45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/09546634.2013.806769","article-title":"Linear morphea: A case series with long-term follow-up of young, methotrexate-treated patients","author":"Koch","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/2229-5178.280253-46","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/2229-5178.280253-47","first-page":"847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.280253-48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","article-title":"Cytokine profiles in localized scleroderma and relationship to clinical features","author":"Kurzinski","year":"2011","journal-title":"Cytokine"},{"key":"key-10.4103\/2229-5178.280253-49","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"key":"key-10.4103\/2229-5178.280253-50","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jaad.2019.01.040","article-title":"Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013","author":"Kumar","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.280253-51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000448171","article-title":"Cyclosporine reduces sclerosis in morphea: A retrospective study in 12 patients and a literature review","author":"Bali","year":"2016","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.280253-52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jamadermatol.2018.5040","article-title":"A case of pansclerotic morphea treated with tocilizumab","author":"Zhang","year":"2019","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/2229-5178.280253-53","first-page":"2538","article-title":"Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children","author":"Roldan","year":"2006","journal-title":"J Rheumatol"},{"key":"key-10.4103\/2229-5178.280253-54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jdcr.2017.12.003","article-title":"Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib","author":"Kim","year":"2018","journal-title":"JAAD Case Rep"},{"key":"key-10.4103\/2229-5178.280253-55","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.34500","article-title":"JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor \u03b2 in systemic sclerosis","author":"Dees","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/2229-5178.280253-56","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamadermatol.2016.2338","article-title":"Treatment of generalized deep morphea with everolimus","author":"Frumholtz","year":"2016","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/2229-5178.280253-57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/18743129014090100030","article-title":"A case report of successful treatment of recalcitrant childhood localized scleroderma with infliximab and leflunomide","author":"Ferguson","year":"2015","journal-title":"Open Rheumatol J"},{"key":"key-10.4103\/2229-5178.280253-58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ced.13352","article-title":"Subcutaneous immunoglobulin for the treatment of deep morphoea in a child","author":"Yamazaki-Nakashimada","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.280253-59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2230.1998.00378.x","article-title":"Disabling morphoea of childhood-beneficial effect of intravenous immunoglobulin therapy","author":"Wollina","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.280253-60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0781.2004.00080.x","article-title":"Suggested mechanisms of action of UVA phototherapy in morphea: A molecular study","author":"El-Mofty","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"key-10.4103\/2229-5178.280253-61","first-page":"467808","article-title":"Updates on morphea: Role of vascular injury and advances in treatment","author":"Sartori-Valinotti","year":"2013","journal-title":"Autoimmune Dis"},{"key":"key-10.4103\/2229-5178.280253-62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.semarthrit.2018.03.003","article-title":"Comparing ultraviolet light A photo (chemo) therapy with methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach","author":"Marrani","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.4103\/2229-5178.280253-63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0365-05962012000100007","article-title":"Localized scleroderma: Assessment of the therapeutic response to phototherapy","author":"Buense","year":"2012","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/2229-5178.280253-64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/pde.13336","article-title":"Orthopedic complications of linear morphea: Implications for early interdisciplinary care","author":"Schoch","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/2229-5178.280253-65","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/acr.23101","article-title":"Predictors of longitudinal quality of life in pediatric localized scleroderma","author":"Ardalan","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:08Z","timestamp":1787163848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_284_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["280253"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_284_19","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}